Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uta Merle

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Infection|July 19, 2021
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learningCarolin E M Jakob, Ujjwal Mukund Mahajan, Marcus Oswald, et al.
Nature Communications|June 13, 2023
Excessive copper impairs intrahepatocyte trafficking and secretion of selenoprotein PMaria Schwarz, Caroline E Meyer, Alina Löser, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2021
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosisStephan Buch, Aneesh Sharma, Eleanor Ryan, et al.
The Lancet. Infectious Diseases|September 16, 2022
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trialHeiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
Research Square|June 30, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseaseVolker Lohmann, Paul Rothhaar, Christian Heuss, et al.
Nature Communications|December 7, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseasePaul Rothhaar, Tomke Arand, Ha Gyu-Thomas Seong, et al.
EMBO Reports|March 23, 2023
Scalable RT-LAMP-based SARS-CoV-2 testing for infection surveillance with applications in pandemic preparednessDan Lou, Matthias Meurer, Svetlana Ovchinnikova, et al.
NPJ Digital Medicine|April 13, 2021
A reporting and analysis framework for structured evaluation of COVID-19 clinical and imaging dataGabriel Alexander Salg, Maria-Katharina Ganten, Andreas Michael Bucher, et al.
Trials|October 7, 2020
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trialMaike Janssen, Ulrike Schäkel, Carine Djuka Fokou, et al.
Journal of Proteome Research|February 4, 2024
Integrative Molecular Structure Elucidation and Construction of an Extended Metabolic Pathway Associated with an Ancient Innate Immune Response in COVID-19 PatientsSamuele Sala, Philipp Nitschke, Reika Masuda, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Infection|July 19, 2021
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learningCarolin E M Jakob, Ujjwal Mukund Mahajan, Marcus Oswald, et al.
Nature Communications|June 13, 2023
Excessive copper impairs intrahepatocyte trafficking and secretion of selenoprotein PMaria Schwarz, Caroline E Meyer, Alina Löser, et al.
Alimentary Pharmacology & Therapeutics|February 10, 2021
Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosisStephan Buch, Aneesh Sharma, Eleanor Ryan, et al.
The Lancet. Infectious Diseases|September 16, 2022
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trialHeiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
Research Square|June 30, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseaseVolker Lohmann, Paul Rothhaar, Christian Heuss, et al.
Nature Communications|December 7, 2025
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe diseasePaul Rothhaar, Tomke Arand, Ha Gyu-Thomas Seong, et al.
EMBO Reports|March 23, 2023
Scalable RT-LAMP-based SARS-CoV-2 testing for infection surveillance with applications in pandemic preparednessDan Lou, Matthias Meurer, Svetlana Ovchinnikova, et al.
NPJ Digital Medicine|April 13, 2021
A reporting and analysis framework for structured evaluation of COVID-19 clinical and imaging dataGabriel Alexander Salg, Maria-Katharina Ganten, Andreas Michael Bucher, et al.
Trials|October 7, 2020
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trialMaike Janssen, Ulrike Schäkel, Carine Djuka Fokou, et al.
Journal of Proteome Research|February 4, 2024
Integrative Molecular Structure Elucidation and Construction of an Extended Metabolic Pathway Associated with an Ancient Innate Immune Response in COVID-19 PatientsSamuele Sala, Philipp Nitschke, Reika Masuda, et al.
Pageof 19